Position in NVS
as of Jun 30, 2026
· filed Aug 11, 2026
Position Value
$486,145
+$12,315 QoQ
Shares Held
3,102
0.0% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.37%
of 13F equity value
Holder Rank
#896
of 1,602 holders
Holding Since
Dec 2024
7 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in NVS Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Millstone Evans Group, LLC holds $7,373,452 across 14 Drug Manufacturers - General names. NVS ranks #5 (6.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
|
9,613 | $2,441,413 | |
| 2 | LLY |
ELI LILLY & Co
|
1,385 | $1,661,210 | |
| 3 | MRK |
Merck & Co., Inc.
|
10,569 | $1,358,116 | |
| 4 | ABBV |
AbbVie Inc.
|
2,498 | $628,596 | |
| 5 | NVS |
Novartis AG
This page
|
3,102 | $486,145 | |
| 6 | BMY |
Bristol Myers Squibb Co
|
4,883 | $281,358 | |
| 7 | AMGN |
Amgen Inc
|
673 | $243,706 | |
| 8 | PFE |
Pfizer Inc
|
6,243 | $150,331 |
All Filings in NVS
Export CSV
7 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $486,145 | 3,102 | Shares | Sole | 2026-08-11 | |
| 2026-03-31 | $473,830 | 3,102 | Shares | Sole | 2026-04-30 | |
| 2025-12-31 | $427,672 | 3,102 | Shares | Sole | 2026-02-02 | |
| 2025-09-30 | $397,800 | 3,102 | Shares | Sole | 2025-10-30 | |
| 2025-06-30 | $375,373 | 3,102 | Shares | Sole | 2025-08-13 | |
| 2025-03-31 | $349,155 | 3,132 | Shares | Sole | 2025-05-05 | |
| 2024-12-31 | $304,774 | 3,132 | Shares | Sole | 2025-02-11 | |
| No filing history on record for this holder in this stock. | ||||||